Reimer, T., Glass, A., Botteri, E., Loibl, S., & D. Gentilini, O. (2020). Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial. Cancers (Basel).
Stile di citazione ChicagoReimer, Toralf, Aenne Glass, Edoardo Botteri, Sibylle Loibl, e Oreste D. Gentilini. "Avoiding Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial." Cancers (Basel) 2020.
Citazione MLAReimer, Toralf, et al. "Avoiding Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial." Cancers (Basel) 2020.